Clinical Trials Logo

Mood clinical trials

View clinical trials related to Mood.

Filter by:

NCT ID: NCT05850221 Recruiting - Depression Clinical Trials

Anaerobic Exercise and Mental Acuity

Start date: April 15, 2023
Phase: N/A
Study type: Interventional

This is a randomized controlled trial to examine the effect of anaerobic activity (e.g., weight training) on gut microbiome metabolism and neurological health in healthy sedentary men.

NCT ID: NCT05717452 Recruiting - Mood Clinical Trials

Effects of a Single Dose of Wild Blueberries on Mood and Executive Function in Healthy Emerging Adults

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

This study aims to investigate whether consuming a drink containing powdered blueberries (equivalent to 150 g of fresh fruit) can improve mood and executive function in healthy emerging adults.

NCT ID: NCT05541887 Recruiting - Anxiety Clinical Trials

Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health

Start date: August 30, 2023
Phase: N/A
Study type: Interventional

Previous studies have shown that polyphenol-rich foods can positively affect cognitive functions, memory, and mood in humans. We hypothesize that both acute and chronic intake of muscadine wine polyphenols will improve cognitive performance and mood through regulating the HPA axis, alleviating inflammation and oxidative stress, and/or inhibiting monoamine oxidase activities

NCT ID: NCT05234476 Recruiting - Depression Clinical Trials

Behavioral Activation Plus Savoring for University Students

Start date: September 6, 2021
Phase: N/A
Study type: Interventional

The current investigation aims to examine whether a brief, two-session, virtual behavioral activation plus savoring intervention will increase daily positive emotion in university students.

NCT ID: NCT05058872 Recruiting - Mood Clinical Trials

Contraceptive Hormone and Reward Measurement (CHARM Study)

CHARM
Start date: October 1, 2021
Phase: Phase 4
Study type: Interventional

Purpose of this study: The purpose of this study is to learn more about how hormonal oral contraceptives affect brain processes and emotional wellbeing. Procedures: If participants agree to participate, the following will happen: 1. Eligibility visit (remote screening session) 2. If participants are eligible to participate in the study, they will be placed in one of two groups. If they are in the first group, they will be asked to take an oral contraception pill ("study drug") every day for 21 days. If they are in the second, they will take a placebo every day for 21 days. A placebo is a pill that looks like medicine but is not real and will have no medical effect on participants. Participants will not get to choose which group they are in, nor will they be told which group they are in. 3. During the three-week period in which participants will take either the study drug or placebo, they will be asked to complete daily check-in surveys on their computer or mobile device. 4. Participants will be asked to attend two additional visits over the course of about three weeks. At these visits, participants will be asked to undergo a urine drug screen, a blood draw, and a magnetic resonance imaging (MRI). They will also be asked to complete behavioral questionnaires.

NCT ID: NCT04630600 Recruiting - Anxiety Clinical Trials

Presence of Aquarium in the Waiting Room of a Geriatric Dental Clinic

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

The participants in this study will be subjected to a specific clinic waiting area ambience (1- no aquarium, 2- presence of aquarium with no fish, and 3- aquarium with fish) for their period of waiting before their intended dental visit and their stress and anxiety levels will be measured. Heart rate, blood pressure will be measured and other upon their arrival into the dental clinic waiting area and then again after 20 minutes of waiting in the waiting area. Anxiety will be measured using a six-item State-Trait Anxiety Inventory (STAI-6) questionnaire and the mood of the participants were assessed for valence and arousal, using the feeling scale, and the felt arousal scale. The data from the three different waiting room settings will be compared and statistically analysed to investigate if an aquarium has an impact, and in that case how.

NCT ID: NCT04414371 Recruiting - Depression Clinical Trials

Tools for Wellbeing COVID-19 National Study of Undergraduate Students

Start date: May 20, 2020
Phase: N/A
Study type: Interventional

The study evaluates the effectiveness of yoga practices on reducing stress, negative emotion, anxiety, and depression and on increasing positive emotion, wellbeing and resilience. The study uses randomized wait-list control. All U.S. undergraduate students in 4-year universities and colleges age 18 or older are eligible to participate.

NCT ID: NCT03948230 Recruiting - Cognitive Change Clinical Trials

Hypo-hydration Mood and Cognition

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

Recently changes in mood and cognition have been reported following minor reductions in hydration status. The aim is to explore that such changes in part at least reflect placebo response; therefore the consumption of plain or coloured water will be compared in drinks designed to differ in their ability to rehydrate.

NCT ID: NCT03935646 Recruiting - Clinical trials for Attention Deficit Hyperactivity Disorder

Acute Effects of Stimulant Medication in College Students With ADHD

Start date: February 11, 2020
Phase: Phase 2
Study type: Interventional

The investigators will examine the acute effects of stimulant medication on executive functioning. The rationale for the proposed study is to examine the efficacy of stimulants for college students with ADHD and help prevent stimulant misuse among college students without ADHD. The working hypothesis is that stimulants, compared to baseline and placebo conditions, will improve executive functioning for college students with ADHD but not for college students without ADHD. Improvements on executive functioning measures (e.g., CPT-IP, Spatial Span) will be examined through 2 (ADHD vs. non-ADHD) x 3 (Baseline, Placebo, Stimulant) repeated measures ANOVAs. Follow-up analyses will include paired comparisons. Expected outcomes are to confirm these hypotheses and demonstrate the need for further study of stimulants. If confirmed, the results will provide pilot data for a larger NIH grant proposal aimed at further examining the acute effects of stimulants (i.e., improved cognitive functioning with stimulants) and comparing them to the acute effects of physical exercise (i.e., improved cognitive functioning immediately after exercise). The investigators expect this outcome to have an important positive impact because it can help support stimulant medication as an effective treatment for college students with ADHD (DuPaul et al., 2012). Additionally, demonstration that stimulants do not improve executive functioning for college students without ADHD can be used to help prevent and discourage stimulant misuse and diversion on college campuses (Hartung et al., 2013).

NCT ID: NCT03801655 Recruiting - Cognitive Change Clinical Trials

OxPALM: Oxford Study on Probiotics and Low Mood

Start date: August 15, 2018
Phase: N/A
Study type: Interventional

Probiotics are live bacteria which have been suggested to have beneficial effects not only on gut function but also on psychological and cognitive functioning. This study will investigate how a specific probiotic influences emotional and cognitive processing in participants with low mood.